MAPT and Alzheimer disease: Among these, the fragment corresponding to the core of tau fibrils in Alzheimer’s Disease (TADC) has emerged as a promising model for inducer-free tau aggregation, reportedly capable of forming fibrils without the use of classical negatively charged cofactors such as heparin or RNA [14,17].